Here are five key notes on the dividend:
1. The dividend is conditioned on the Irish Court administrative approval, which Medtronic expects to receive by early March 2015.
2. The dividend is payable on April 17 to shareholders of record at the close of business on March 30.
3. This quarterly dividend is 9 percent more than the previous year.
4. Medtronic committed to returning 50 percent of its free cash flow to shareholders through dividend and share repurchase options.
5. Medtronic expects all or a portion of the distribution could be treated as a return of capital to U.S. shareholders for U.S. tax purposes.
More articles on orthopedic devices:
7 key trends in joint replacement customization
Amedica files FDA application for spinal implant spacers with porous silicon nitride center—6 things to know
Smith & Nephew launches new suture anchor
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
